+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
RUBICON

Rubicon Research Share Price

 

 

Rubicon Research live price: ₹1,520.20. It opened at ₹1,530 vs previous close ₹1,525; intraday high/low: ₹1,560/₹1,490. The 50 DMA stands at ₹1,297.80.

Rubicon Research Performance

  • Today's Low
  • ₹1,490
  • Today's High
  • ₹1,560
  • 52 Week Low
  • ₹571
  • 52 Week High
  • ₹1,560
  • Open Price₹1,530
  • Previous Close₹1,525
  • Volume199,321
  • 50 DMA₹1,297.80
  • 100 DMA₹1,129.80
  • 200 DMA-

Rubicon Research Chart

Investment Returns

  • Over 1 Month + 7.31%
  • Over 3 Month + 61.95%
  • Over 6 Month + 133.86%
  • Over 1 Year + 213.44%

Smart Investing Starts Here Start SIP with Rubicon Research for Steady Growth!

Invest Now

Rubicon Research Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 102
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 25,164
  • P/B Ratio
  • 19.5
  • Average True Range
  • 72
  • EPS
  • 14.9
  • Dividend Yield
  • 0
  • MACD Signal
  • 62.6
  • RSI
  • 64.45
  • MFI
  • 76.41

Latest Stock News Updates

Rubicon Research zooms 128% so far in 2026; what's driving pharma stock?

Share price of Rubicon Research hit a new high of 1,545.60, rallying 6 per cent on the BSE in Thursday's intra-day deals in an otherwise weak market.

Rubicon Research Ltd - 544578 - Filing Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only, In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20, 2023

Filing of Scheme of Merger of KIA Health Tech Pvt Ltd (WOS) with Rubicon Research Limited - for Disclosure Purposes Only, in terms of the Exemption under Para 4 of SEBI Master circular No. SEBI/HO/CFD/POD-2/p/CIR/2023/93 dated June 20, 2023

Rubicon Research Ltd - 544578 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 (''SEBI Listing Regulations'') - Acquisition of a Manufacturing Facility in USA.

Rubicon Research Financials

Rubicon Research Technicals

EMA & SMA

Current Price
₹1,520.20
-5.2 (-0.34%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 14
  • 20 Day
  • ₹1,434.10
  • 50 Day
  • ₹1,297.80
  • 100 Day
  • ₹1,129.80
  • 200 Day
  • -

Resistance and Support

1523.23 Pivot Speed
  • R3 1,627.50
  • R2 1,593.70
  • R1 1,557.00
  • S1 1,486.50
  • S2 1,452.70
  • S3 1,416.00

Rubicon Research Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results & Final Dividend
2026-02-03 Quarterly Results
2025-11-13 Quarterly Results
Date Purpose Remarks
2026-08-07 FINAL Rs.1.50 per share(150%)Final Dividend
View Rubicon Research Dividend History Arrow

Rubicon Research Shareholding Pattern

59.76%
23.29%
7.52%
7.23%
2.2%

About Rubicon Research

Rubicon Research are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States.(Source : Prospectus Page No: 249) View More
  • NSE Symbol
  • RUBICON
  • BSE Symbol
  • 544578
  • ISIN
  • INE506V01022

Similar Stocks to Rubicon Research

Rubicon Research FAQs

Rubicon Research share price is ₹1,520 As on 27 July, 2026 | 00:40

The Market Cap of Rubicon Research is ₹25164.2 Cr As on 27 July, 2026 | 00:40

The P/E ratio of Rubicon Research is 102 As on 27 July, 2026 | 00:40

The PB ratio of Rubicon Research is 19.5 As on 27 July, 2026 | 00:40

The 52 week High & Low of Rubicon Research is ₹1560/₹570.8 respectively As on 27 July, 2026 | 00:40

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23